Medicare Enrolled
Dr. Steven Lovitt, M.D.
Neurology · Allentown, PA
Practice pattern: Mixed Practice
— Diverse clinical practice across multiple procedure types
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Lovitt from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Lovitt?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Lovitt
Dr. Steven Lovitt is a neurology specialist in Allentown, PA, with 20 years of NPI registration. Based on federal Medicare data, Dr. Lovitt performed 11,788 Medicare services in 2023. These records do not provide a deduplicated patient total.
Between the years covered by Open Payments, Dr. Lovitt received a total of $216,494 from 79 pharmaceutical and/or device companies across 1656 payment records. A record can group multiple payments. These transfers are publicly reported through CMS Open Payments. Disclosure alone does not establish their effect on care. A reliable breakdown by payment category is not available in this snapshot. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Lovitt is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 20 years of NPI registration
▲ Top 3% volume in PA
$216,494 industry payments
Medicare Practice Summary — 2023
Medicare Utilization ↗11,788
Medicare services
Top 3% in PA for neurology
Not available
Unique patients (not deduplicated)
$40
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Immune globulin infusion (Gammagard) An injection of immune globulin (Gammagard Liquid) to provide antibodies. The dose specified is 500 mg. |
10,670 | $36 | $116 |
| Electromyography of arm or leg muscles A test that measures the electrical activity in the muscles of the arm or leg using a needle electrode. It helps evaluate the health of muscles and the nerve cells that control them. |
278 | $66 | $238 |
| Additional hour of intravenous infusion This code represents each additional hour of intravenous infusion beyond the initial hour for therapy, prevention, or diagnosis. |
239 | $15 | $58 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
121 | $96 | $326 |
| Intravenous infusion, 1 hour or less Administration of medication or fluid directly into a vein for therapeutic, preventive, or diagnostic purposes. The procedure lasts one hour or less. |
116 | $47 | $213 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
114 | $121 | $465 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
73 | $60 | $220 |
| Nerve conduction studies, 11-12 A diagnostic test that measures how well nerves send electrical signals. It involves performing 11 to 12 separate nerve conduction studies. |
60 | $180 | $800 |
| New patient office visit, complex (60-74 min) | 47 | $160 | $592 |
| Nerve conduction studies, 13 or more A diagnostic test that measures how well nerves send electrical signals. This code applies when 13 or more individual nerve studies are performed. |
30 | $189 | $907 |
| Nerve conduction study, 9-10 studies A diagnostic test that measures how well nerves send electrical signals. It involves performing 9 to 10 separate nerve conduction studies to evaluate nerve function. |
29 | $100 | $340 |
| Office visit, established patient, complex (40-54 min) An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter. |
11 | $129 | $372 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. These counts do not measure clinical quality or years of experience.
93.5% high complexity
0.0% medium
6.5% routine
Industry Payment Transparency
Open Payments through 2024 ↗$216,494
Total received (2018-2024)
Avg $30,928/year across 7 years
Top 5% in PA for neurology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
79
Companies
1,656
Payment records
Payments are publicly reported; disclosure does not establish legality · Not evidence of wrongdoing · How to interpret →
Payment categories are unavailable while the source breakdown is being rebuilt. Company and year totals do not identify how much belongs to each category.
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$53
2023
$5,418
2022
$22,618
2021
$20,037
2020
$15,106
2019
$82,724
2018
$70,538
Payments by company (2024)
Alexion Pharmaceuticals, Inc.
$31
Abbott Laboratories
$22
Top 3 companies account for 100.0% of 2024 payments
All-time payments by company (2018-2024) ›
Alexion Pharmaceuticals, Inc.
$195,088
Sunovion Pharmaceuticals Inc.
$2,286
GENZYME CORPORATION
$1,544
Novartis Pharmaceuticals Corporation
$1,483
Biogen, Inc.
$1,158
Teva Pharmaceuticals USA, Inc.
$1,145
Supernus Pharmaceuticals, Inc.
$1,046
Grifols USA, LLC
$1,041
Amgen Inc.
$962
EMD Serono, Inc.
$877
UCB, Inc.
$837
SK Life Science, Inc.
$759
CSL Behring
$720
ARGENX US, INC.
$597
Horizon Therapeutics plc
$510
Amneal Pharmaceuticals LLC
$438
Genentech USA, Inc.
$401
ACADIA Pharmaceuticals Inc
$332
Neurocrine Biosciences, Inc.
$329
Acorda Therapeutics, Inc
$320
ABBVIE INC.
$285
Abbott Laboratories
$243
Bausch Health US, LLC
$225
PFIZER INC.
$202
Lilly USA, LLC
$198
Celgene Corporation
$192
AbbVie Inc.
$181
Nevro Corp.
$171
EISAI INC.
$161
Biohaven Pharmaceuticals, Inc.
$159
Eisai Inc.
$156
Biohaven Pharmaceutical Holding Company Ltd.
$151
Kyowa Kirin, Inc.
$132
Allergan, Inc.
$121
Upsher-Smith Laboratories LLC
$111
Impax Laboratories, Inc.
$108
Allergan Inc.
$105
Lundbeck LLC
$105
Assertio Therapeutics, Inc.
$97
Takeda Pharmaceuticals U.S.A., Inc.
$95
Adamas Pharmaceuticals, Inc.
$94
Merz North America, Inc.
$82
CATALYST PHARMACEUTICALS, INC.
$80
Avion Pharmaceuticals
$76
Mitsubishi Tanabe Pharma America, Inc.
$76
Mallinckrodt Hospital Products Inc.
$74
IMPEL PHARMACEUTICALS INC.
$74
Sumitomo Pharma America, Inc.
$60
Endo Pharmaceuticals Inc.
$60
Bayer HealthCare Pharmaceuticals Inc.
$59
GE HEALTHCARE
$49
Egalet US Inc
$48
Vertical Pharmaceuticals, LLC
$44
Mallinckrodt LLC
$40
Octapharma USA, Inc.
$39
Alnylam Pharmaceuticals Inc.
$36
ARBOR PHARMACEUTICALS, INC.
$35
E.R. Squibb & Sons, L.L.C.
$34
ASSERTIO THERAPEUTICS, Inc.
$31
Promius Pharma LLC
$29
Corium, LLC
$25
LivaNova USA, Inc.
$22
SANOFI-AVENTIS U.S. LLC
$21
JAZZ PHARMACEUTICALS INC.
$20
Apria Healthcare LLC
$19
Greenwich Biosciences, Inc.
$17
GRT US Holding, Inc.
$17
Mylan Specialty L.P.
$17
Mylan Pharmaceuticals Inc.
$17
Averitas Pharma Inc.
$15
Currax Pharmaceuticals LLC
$15
Strongbridge US INC.
$14
Janssen Pharmaceuticals, Inc
$14
BANNER LIFE SCIENCES, LLC
$13
GE HealthCare
$13
Shire North American Group Inc
$13
UPSHER-SMITH LABORATORIES LLC
$12
Retrophin, Inc.
$10
Piramal Imaging Limited
$8
Top 3 companies account for 91.9% of all-time payments
Associated products mentioned in payments ›
(820) Cholbam · ACTHAR · ADLARITY · ADUHELM · AIMOVIG · AJOVY · AMPYRA · APTIOM · AUBAGIO · AUSTEDO · AVONEX · Aimovig · BAFIERTAM · BOTOX · BOTOX THERAPEUTIC · Betaseron · Briviact · CAMBIA · COPAXONE · Cambia · DIVIGEL · DUOPA · Dhivy · EMGALITY · Edarbi · Enspryng · Epidiolex · FIRDAPSE · Fycompa · GAMMAGARD · GILENYA · GOCOVRI · Gamunex-C · Glatiramer Acetate · Gralise · Hizentra · Horizant · INBRIJA · INFINITY · INGREZZA · KESIMPTA · KEVEYIS · KYNMOBI · LEMTRADA · LUMIZYME · LYRICA · MAVENCLAD · MAYZENT · MIGRANAL · Mavenclad · Medela · NASCOBAL · NEURACEQ · NOURIANZ · NUPLAZID · NURTEC ODT · Neupro · Nourianz · OCREVUS · OCTAGAM IMMUNE GLOBULIN (HUMAN) · ONGENTYS · ONPATTRO · ONZETRA XSAIL · OXTELLAR XR · Ocrevus · Ongentys · Ozanimod · Privigen · QUDEXY XR Topiramate Extended Release Capsules · QULIPTA · QUTENZA · Qutenza · RYTARY · Radicava · Rebif · SOLIRIS · SPINRAZA · SPRIX · SUNOSI · Senza Spinal Cord Stimulation System · Soliris · TECFIDERA · TOSYMRA · TOSYMRA SUMATRIPTAN NASAL SPRAY · TROKENDI XR · TYSABRI · Trudhesa · UBRELVY · ULTOMIRIS · UPLIZNA · VNS - Sentiva · VRAYLAR · VUMERITY · VYEPTI · VYVGART · Vimpat · XCOPRI · XEOMIN · ZEPOSIA · ZOMIG · Zembrace
Should you be concerned? Industry payments are disclosed through CMS Open Payments. Disclosure alone does not establish their purpose, legality, or effect on care. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Geographic Context
Neurologists in nearby ZIP areas
106
County median income
$77,493
Nearest hospital to ZIP centroid (approximate)
LEHIGH VALLEY HOSPITAL
4.2 mi
4.2 mi
Data Sources
| Provider Registry | ✓ NPPES | NPPES snapshot; verify current record |
| Medicare Enrollment | ✓ PECOS | PECOS snapshot |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not included | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Lovitt is a mixed practice specialist, with above-average Medicare volume (top 3% in PA), with 20 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Lovitt experienced with immune globulin infusion (gammagard)?
Based on Medicare claims data, Dr. Lovitt performed 10,670 immune globulin infusion (gammagard) services. These records cover Medicare fee-for-service activity, including eligible younger beneficiaries; they do not measure total practice volume or clinical quality.
Does Dr. Lovitt receive payments from pharmaceutical companies?
Yes. Dr. Lovitt received a total of $216,494 from 79 companies across 1,656 payment records. A record can group multiple payments. These transfers are publicly disclosed through CMS Open Payments. Disclosure alone does not establish their legality or effect on care. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Lovitt's costs compare to other neurologists in Allentown?
Dr. Lovitt's average Medicare payment per service is $40. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Lovitt) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating the presence of registry, enrollment, activity or payment records, not verified experience or clinical quality. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Source publication dates and the snapshots loaded on this site can differ. Rebuilding a page does not refresh its source records. Check the Medicare reporting year and the payment interval shown above; consult the linked official sources for newer releases and current registry details. See our data freshness policy →
Explore related providers
Specialty guide
Understanding Neurology
Common procedures, typical costs, and what industry payments mean in neurology.
Same specialty & city
Neurologists in Allentown
Browse neurologists in Allentown ranked by procedure volume and transparency data.
Highest volume
Top Neurologists in PA
Neurologists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Neurologists in PA
Which PA neurologists receive the most from drug and device companies.
By company
Alexion Pharmaceuticals, Inc. Payments to Doctors
See all physicians who received payments from Alexion Pharmaceuticals, Inc.
By company
Sunovion Pharmaceuticals Inc. Payments to Doctors
See all physicians who received payments from Sunovion Pharmaceuticals Inc.
By company
GENZYME CORPORATION Payments to Doctors
See all physicians who received payments from GENZYME CORPORATION.
About this page
This page combines public CMS records with calculated summaries and explanatory procedure labels. These transformations are not verbatim federal records. Sources: NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology